These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21558471)

  • 21. Louisiana hospital reduces pneumonia pharmacy costs by 26%.
    Perform Improv Advis; 2003 Jul; 7(7):101-3, 93. PubMed ID: 12934429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VTE: From partnership to prevention.
    Savage S
    Health Serv J; 2012 Apr; 122(6301):26-7. PubMed ID: 22666994
    [No Abstract]   [Full Text] [Related]  

  • 23. Lot quality assurance sampling (LQAS) for monitoring a leprosy elimination program.
    Gupte MD; Narasimhamurthy B
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):143-9. PubMed ID: 10472366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cost of functioning of a centralised pharmaceutical unit: evaluation of mean costs of chemotherapy preparations according to the level of production of the unit].
    Galy G; Bauler S; Buchi M; Pirot F; Pivot C
    Bull Cancer; 2011 Oct; 98(10):1153-63. PubMed ID: 22001702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage.
    Greenland K; Rondy M; Chevez A; Sadozai N; Gasasira A; Abanida EA; Pate MA; Ronveaux O; Okayasu H; Pedalino B; Pezzoli L
    Trop Med Int Health; 2011 Jul; 16(7):863-8. PubMed ID: 21481106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field trial of applicability of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma.
    Myatt M; Limburg H; Minassian D; Katyola D
    Bull World Health Organ; 2003; 81(12):877-85. PubMed ID: 14997240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current challenges in European oncology pharmacy practice.
    Hoppe-Tichy T
    J Oncol Pharm Pract; 2010 Mar; 16(1):9-18. PubMed ID: 20015932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of lot quality assurance sampling for leprosy elimination monitoring--examination of some critical factors.
    Gupte MD; Murthy BN; Mahmood K; Meeralakshmi S; Nagaraju B; Prabhakaran R
    Int J Epidemiol; 2004 Apr; 33(2):344-8. PubMed ID: 15082637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further observations on comparison of immunization coverage by lot quality assurance sampling and 30 cluster sampling.
    Singh J; Jain DC; Sharma RS; Verghese T
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):267-73. PubMed ID: 9279988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
    Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Draft technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. American Society of Hospital Pharmacists, Council on Professional Affairs.
    Am J Hosp Pharm; 1993 Jul; 50(7):1440-52. PubMed ID: 8362882
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of surface contamination in a hospital hematology--oncology pharmacy.
    Touzin K; Bussières JF; Langlois E; Lefebvre M
    J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package.
    Kleinberg ML; Duafala ME
    Am J Hosp Pharm; 1988 Jan; 45(1):109-15. PubMed ID: 3348222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit.
    Delmas A; Gordien JB; Bernadou JM; Roudaut M; Gresser A; Malki L; Saux MC; Breilh D
    J Pharm Biomed Anal; 2009 Jul; 49(5):1213-20. PubMed ID: 19362442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost savings from dose rounding of biologic anticancer agents in adults.
    Winger BJ; Clements EA; DeYoung JL; O'Rourke TJ; Claypool DL; Vachon S; VanDyke TH; Zimmer-Young J; Kintzel PE
    J Oncol Pharm Pract; 2011 Sep; 17(3):246-51. PubMed ID: 20332175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microcosting method for small-volume injectables.
    Hatoum HT; Witte KW; Biedron GT; Hutchinson RA
    Am J Hosp Pharm; 1986 Feb; 43(2):348-54. PubMed ID: 3953595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance for the JCAHO standards.
    Chase PA
    Am J Hosp Pharm; 1991 Jul; 48(7):1550-2. PubMed ID: 1882891
    [No Abstract]   [Full Text] [Related]  

  • 38. Inadequate medical order writing and delivery: a cause of unnecessary hospital costs.
    Larson EB; Dowell S; Scott DH
    QRB Qual Rev Bull; 1984 Nov; 10(11):353-5. PubMed ID: 6441138
    [No Abstract]   [Full Text] [Related]  

  • 39. Selecting, developing, and evaluating indicators.
    Angaran DM
    Am J Hosp Pharm; 1991 Sep; 48(9):1931-7. PubMed ID: 1928135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacoeconomic aspects of oral cytostatic agents].
    Poquet Jornet JE; Carrera-Hueso FJ; Gasent Blesa JM; Peris Godoy M
    Farm Hosp; 2011 May; 35 Suppl 2():25-31. PubMed ID: 22445506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.